Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.
about
Educating health professionals about drug and device promotion: advocates' recommendationsEarly relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: a randomized controlled trial [ISRCTN38432711].Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxenLong-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general populationNSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen SpeciesMolecular cancer prevention: Current status and future directionsRegulation of genes in the arachidonic acid metabolic pathway by RNA processing and RNA-mediated mechanismsDisease risk score as a confounder summary method: systematic review and recommendationsCardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balanceCOX-2 chronologyAn update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitorsDrugs for pain management in dentistryNon-steroidal antiinflammatory drugs and the risk of acute myocardial infarctionIs there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in JapanUnmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseasesDo older adults using NSAIDs have a reduced risk of colorectal cancer?Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysisTolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literatureCardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)Role of the cyclooxygenase pathway in the protection against postischemic stunning in conscious sheepAn economic model of long-term use of celecoxib in patients with osteoarthritisBalancing the cyclooxygenase portfolioIncreased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugsThe coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risksCardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxibThe David Y. Graham lecture: use of nonsteroidal antiinflammatory drugs in a COX-2 restricted environmentBoswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical dataCardiovascular risk, hypertension, and NSAIDsIs sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control studyTwelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary taleRisk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias ToolNovel data-mining methodologies for adverse drug event discovery and analysisWhy we need easy access to all data from all clinical trials and how to accomplish itPharmacovigilance Using Clinical NotesRisk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.Sulforaphane inhibits prostaglandin E2 synthesis by suppressing microsomal prostaglandin E synthase 1.[Revision rates in journal publications on joint prostheses with noticeably high failure rates in register data sets].Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks
P2860
Q21144686-D69FC5ED-81B1-4258-A8FF-E67863558E8BQ21245659-B56250DD-7815-487E-9425-175F20EAA5AEQ21254655-8607D4D0-D2F3-47B1-AE4C-0D1EF8127013Q24621123-B2560094-10B8-47BB-ABD9-D563AEFAE440Q24816136-C20B8205-5AC3-4AC1-B67B-6D69B41900B3Q26784322-C4845B90-578F-400B-AC86-5FFB6568E94AQ26797207-A4CACD5B-C3CC-4D65-B53B-82FD0AD6AFCAQ26849624-3BC75537-11F4-42B3-B31F-4855F78628E2Q26999267-30FF9611-8850-4248-8D61-C861C0EE14D5Q28191924-2AB99D40-43EC-4A81-A79C-B2EF43DFF007Q28192719-558375A0-49ED-4E52-9624-2679FAF62FC1Q28193309-FD466E8A-3B4E-4FCB-BA82-DF3E76E6CEBDQ28194546-E9400230-685B-40EB-A9ED-2A6F87388862Q28196509-7DFDA688-DEA3-430B-A91F-AC9D0B309FBEQ28196511-6A2BFAC1-A11A-4D61-A737-AA24674C7974Q28199071-05683DB3-5189-4D89-8551-9FFE4866011EQ28199775-25A83C86-470F-4EC4-9F66-665DDBE1C9ECQ28199809-A5081498-9024-49FD-B74B-56C638D8B0C6Q28200524-DF04BE62-5AC6-4A90-B623-B8F878E8B74FQ28210177-4709A48B-2B3F-42FD-8B06-2F2DA4194D47Q28210559-E6D66EA6-2A3D-4705-9936-5763D0BAB887Q28217943-22AE2812-E2B2-4362-BD05-9F232F2DFE21Q28218005-E1DA5C66-D596-4DE7-B9DD-AF50CBA1774BQ28218310-A0C94762-83F1-4539-85A6-6C9399ABD961Q28218432-4DF2F39F-3024-42C4-94AD-AEAA09067BEEQ28219195-85D78EAC-DDF3-40E5-8FF9-AA9A029BFE50Q28222097-03C78683-6FEB-4CC6-849B-B66B2D50AB71Q28222253-333F8562-52D7-48E5-8BAD-99A4B1888CADQ28237079-F1E7326A-67D0-4D13-B816-75E955BD2A3EQ28298198-7ED77323-F9EB-41BD-B04F-2E16DF0375FFQ28387103-7A680C48-6809-4F42-AC4F-51FF8F057497Q28475531-8084EA54-A1C4-42E0-A1EB-F10D0E71081FQ28551188-1DFCF8DE-AFD8-40EE-ACAC-8E6C12599382Q28681788-F9754D88-1A7E-463B-838F-995987CBCF10Q28732492-77493DB1-5507-436A-913C-4CBE6FFD7E7FQ30058397-CF698F2B-36FA-4895-BDB7-C4B236E32406Q30234512-91FE557A-C7D9-4D95-B0FE-35ABE0B8E941Q30423875-EC2D21A4-BE29-4F46-9CFE-F83BA886B49EQ30558799-872C5E8D-8E2D-4EFE-BB1D-39D70A0B98EFQ30629677-64AC952C-8B98-4532-8111-ECFAE69847C1
P2860
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Risk of acute myocardial infar ...... gs: nested case-control study.
@en
Risk of acute myocardial infar ...... gs: nested case-control study.
@nl
type
label
Risk of acute myocardial infar ...... gs: nested case-control study.
@en
Risk of acute myocardial infar ...... gs: nested case-control study.
@nl
prefLabel
Risk of acute myocardial infar ...... gs: nested case-control study.
@en
Risk of acute myocardial infar ...... gs: nested case-control study.
@nl
P2093
P1433
P1476
Risk of acute myocardial infar ...... gs: nested case-control study.
@en
P2093
Craig Cheetham
David Campen
David J Graham
Gerald Levy
Michele Spence
Stanford Shoor
Wayne A Ray
P304
P356
10.1016/S0140-6736(05)17864-7
P407
P577
2005-02-01T00:00:00Z